The Hunt for Value in Value-Based Care: How to Meet Stakeholders' Evolving Demands

The CPC and CBEx Annual Congress, on October 6-8, creates an interactive environment for cancer care stakeholders to explore and share practical approaches to relevant issues.

CPC Steering Committee Member Frederick Schnell, MD, FACP, Community Oncology Alliance, highlights his keynote session, “The Hunt for Value in Value-Based Care: How to Meet Stakeholders’ Evolving Demands,” where panelists will discuss practice consolidation, Medicare Advantage, and what the future holds for value-based cancer care.

Register today to improve your practical knowledge about how to effectively implement cancer care at home so it best serves the patients.

Transcript:

Frederick Schnell, MD, FACP: Good day. My name is Dr Fred Schnell, and I'm very happy to be here. I am the chief medical officer for the Community Oncology Alliance as well as its subsidiary, the National Cancer Treatment Alliance. So, I've got a pretty full plate. All of it's revolving around cancer care. And I'm very interested in or very engaged in the upcoming conference.

So, I'm here to talk with you about the Cancer Care Business Exchange and Clinical Pathways Congress annual meeting that's upcoming shortly. This particular session that I want to highlight is entitled, “The Hunt for Value in Value-Based Care: How to Meet Shareholders’ Evolving Demands.”

So, this meeting and this particular topic are critically important for our cancer care delivery, I think. Cancer care has been trending toward a value-based platform for a number of years but is still facing challenges for practices across the country and other institutions to reach the endpoint.

Many things have gone on in the last several years as this became a more prominent subject. There's been a lot of practice consolidation. We've weathered the Oncology Care Model, which I was very involved in. And now we're transitioning into the EOM program that's sponsored by CMS, and there's lots going on in the marketplace.

And in addition, there's been tremendous developments in technology, and sometimes competing stakeholder interests can complicate the pursuit of value-based care and we're going to try to shine some light on those issues come October.

Our session at the Congress is going to be nearly an hour in length. It's going to cover a variety of issues in that depth of time. We're going to address current insights and trends impacting cancer care now and, more importantly, in the future. We want to address how self-insured employers have become a new focus for cancer care benefits and how that's impacting other stakeholders, including the provider community and actually, most of oncology care.

Medicare Advantage is going to be a very important part of the discussion. That is a rapidly growing form of insurance in the marketplace and it is very focused on creating value for the Medicare constituency that it covers. And we'll be talking quite a bit about that during the meeting.

My main interest personally in this session, because it's what I'm doing, is the process of building networks and making those networks value based. That is the Holy Grail of this journey, and anyone that's involved in delivering cancer care right now has to demand excellence. And in doing that we hope to pursue that in the clinics across the country, and we also believe that we have business model proposals that may make that easier to do, though none of this is easy. It's essential that we get sound platforms to deliver care and make them durable and make them achievable and of interest to who have become our main stakeholders, and that is the self-insured business community.

My selfish key interest is fostering the infrastructure that we're building within the Community Oncology Alliance. I think it is impactful to the entire delivery community on the side that we're working on, which is predominantly self-insured employers and Medicare. And we've engaged multiple parties in those pillars and want to explore some of those at various points during the Congress, which is upcoming.

So, in conclusion, we hope to see you in October at the CPC+CBEx meeting. We already have more than 400+ cancer care professionals registered, and we'd love to have you along. And certainly we have room at the table for anyone interested to come and be part of our initiative in October.